Erenumab

ATC N02CD01 · 9 markets · 26 records

Erenumab 9 markets · 26 records Forms

AU 5 records · 3 strengths

  • 140 mginjectionAIMOVIG erenumab 140 mg/mL solution for injection in pre-filled penAIMOVIG erenumab 140 mg/mL solution for injection in pre-filled syringe also in US·ES unknown
  • 70 mginjectionAIMOVIG erenumab (rch) 70 mg/mL solution for injection in pre-filled penAIMOVIG erenumab (rch) 70 mg/mL solution for injection in pre-filled syringe also in US·ES unknown

Records without a stated strength · 1 AIMOVIG

US 4 records · 2 strengths

CA 4 records · 2 strengths

SG 4 records · 2 strengths

GB 2 records · 2 strengths

ES 2 records · 2 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 AIMOVIG SOLUTION FOR INJECTION IN PRE-FILLED PEN 140MG/ML

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 AIMOVIG

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.